- Home
- STOK vs PLYM Comparison
STOK vs PLYM Comparison
Compare STOK & PLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- PLYM
- Stock Information
- Founded
- STOK 2014
- PLYM 2011
- Country
- STOK United States
- PLYM United States
- Employees
- STOK N/A
- PLYM N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- PLYM Real Estate Investment Trusts
- Sector
- STOK Health Care
- PLYM Real Estate
- Exchange
- STOK Nasdaq
- PLYM Nasdaq
- Market Cap
- STOK 721.4M
- PLYM 854.7M
- IPO Year
- STOK 2019
- PLYM 2017
- Fundamental
- Price
- STOK $11.45
- PLYM $19.02
- Analyst Decision
- STOK Strong Buy
- PLYM Buy
- Analyst Count
- STOK 7
- PLYM 8
- Target Price
- STOK $21.40
- PLYM $24.50
- AVG Volume (30 Days)
- STOK 562.4K
- PLYM 339.8K
- Earning Date
- STOK 11-05-2024
- PLYM 11-06-2024
- Dividend Yield
- STOK N/A
- PLYM 5.05%
- EPS Growth
- STOK N/A
- PLYM N/A
- EPS
- STOK N/A
- PLYM 0.01
- Revenue
- STOK $16,742,999.00
- PLYM $201,569,000.00
- Revenue This Year
- STOK $103.04
- PLYM N/A
- Revenue Next Year
- STOK N/A
- PLYM $6.60
- P/E Ratio
- STOK N/A
- PLYM $1,398.90
- Revenue Growth
- STOK 81.08
- PLYM 2.64
- 52 Week Low
- STOK $4.09
- PLYM $18.08
- 52 Week High
- STOK $17.58
- PLYM $25.18
- Technical
- Relative Strength Index (RSI)
- STOK 41.75
- PLYM 48.00
- Support Level
- STOK $11.80
- PLYM $18.49
- Resistance Level
- STOK $12.58
- PLYM $19.21
- Average True Range (ATR)
- STOK 0.83
- PLYM 0.38
- MACD
- STOK -0.06
- PLYM 0.13
- Stochastic Oscillator
- STOK 8.32
- PLYM 82.61
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.
About PLYM Plymouth Industrial REIT Inc.
Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income primarily from the rental revenue through its properties.